Comprehensive Psychiatry
Volume 49, Issue 6 , Pages 561-569 , November 2008

Occupational functioning and impairment in adults with body dysmorphic disorder

  • Elizabeth R. Didie

      Affiliations

    • Butler Hospital, Providence, RI 02906, USA
    • Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI 02912, USA
    • Corresponding Author InformationCorresponding author. Butler Hospital, Providence, RI 02906, USA. Tel.: +1 401 455 6466; fax: +1 401 455 6539.
    • ,
  • William Menard

      Affiliations

    • Butler Hospital, Providence, RI 02906, USA
    • ,
  • Adam P. Stern

      Affiliations

    • Brown University, Providence, RI 02912, USA
    • ,
  • Katharine A. Phillips

      Affiliations

    • Butler Hospital, Providence, RI 02906, USA
    • Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI 02912, USA

References 

  1. Rief W, Buhlmann U, Wilhelm S, Borkenhagen A, Brahler E. The prevalence of body dysmorphic disorder: a population-based survey. Psychol Med. 2006;36:877–885
  2. Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Saric R, Lang KY, Cullen BAM, et al. The relationship of obsessive compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry. 2000;48:287–293
  3. Otto MW, Wilhelm S, Cohen LS, Harlow BL. Prevalence of body dysmorphic disorder in a community sample of women. Am J Psychiatry. 2001;158:2061–2063
  4. Faravelli C, Salvatori S, Galassi F, Aiazzi L, Drei C, Cabras P. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol. 1997;32:24–29
  5. Phillips KA, Menard W, Fay C, Pagano ME. Psychosocial functioning and quality of life in body dysmorphic disorder. Compr Psychiatry. 2005;46:254–260
  6. Phillips KA. Quality of life for patients with body dysmorphic disorder. J Nerv Ment Dis. 2000;188:170–175
  7. Phillips KA, Diaz S. Gender differences in body dysmorphic disorder. J Nerv Ment Dis. 1997;185:570–577
  8. Veale D, Boocock A, Gournay K, Dryden W, Shah F, Willson R, et al. Body dysmorphic disorder: a survey of fifty cases. Br J Psychiatry. 1996;169:196–201
  9. Didie ER, Tortolani C, Walters M, Menard W, Fay C, Phillips KA. Social functioning in body dysmorphic disorder: assessment considerations. Psychiatr Q. 2006;77:223–229
  10. Phillips KA, Coles ME, Menard W, Yen S, Fay C, Weisberg RB. Suicidal ideation and suicide attempts in body dysmorphic disorder. J Clin Psychiatry. 2005;66:717–725
  11. Perugi G, Akiskal HS, Giannotti D, Frare F, DiVaio S, Cassano GB. Gender-related differences in body dysmorphic disorder (dysmorphophobia). J Nerv Mental Dis. 1997;185:578–582
  12. Frare F, Perugi G, Ruffolo G, Toni C. Obsessive-compulsive disorder and body dysmorphic disorder: a comparison of clinical features. Eur Psychiatry. 2004;19:292–298
  13. Fontenelle LF, Telles LL, Nazar BP, de Menezes GB, do Nascimento AL, Mendlowicz MV, et al. A sociodemographic, phenomenological, and long-term follow-up study of patients with body dysmorphic disorder in Brazil. Int J Psychiatry Med. 2006;36:243–259
  14. Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A, et al. Functional impairment in social phobia. J Clin Psychiatry. 1994;55:322–331
  15. Hollander E, Allen A, Kwon J, Aronowitz B, Schmeidler J, Wong C, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry. 1999;56:1033–1039
  16. Phillips KA. An open-label study of escitalopram in body dysmorphic disorder. Int Clin Psychopharmacol. 2006;21:177–179
  17. Phillips KA, Albertini RS, Rasmussen SA. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Arch Gen Psychiatry. 2002;59:381–388
  18. Phillips KA, Najjar F. An open-label study of citalopram in body dysmorphic disorder. J Clin Psychiatry. 2003;64:715–720
  19. Ware JE. SF-36 health survey manual and interpretation guide. Boston (MA): The Health Institute, New England Medical Center; 1993;
  20. Phillips KA, Rasmussen SA. Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study. Psychosomatics. 2004;45:438–444
  21. Carino G, Costello EJ, Angold A. Assessing functional impairment and social adaptation for child mental health services research. Ment Health Serv Res. 1999;1:93–108
  22. Winters NC, Collett BR, Myers KM. Ten-year review of rating scales: scales assessing functional impairment. Am Acad Child Adolesc Psychiatry. 2005;44:309–338
  23. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60:427–435
  24. Rytsala HJ, Melartin TK, Leskela US, Sokero TP, Lestela-Mielonen PS, Isometsa ET. Functional and work disability in major depressive disorder. J Nerv Ment Dis. 2005;193:189–195
  25. Hollfield M, Katon W, Skipper B, Chapman T, Ballenger JC, Mannuzza S, et al. Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry. 1997;154:766–772
  26. Ettigi P, Meyerhoff AS, Chirban JT, Jacobs RJ, Wilson RR. The quality of life and employment in panic disorder. J Nerv Ment Dis. 1997;185:368–372
  27. Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics. 2005;46:317–325
  28. Keller MB, Lavori PW, Friedman B, Nielson E, Endicott J, McDonald P, et al. The Longitudinal Interval Follow-up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry. 1987;44:540–548
  29. Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB. The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med. 1999;29:869–878
  30. Warshaw MG, Keller MB, Stout RL. Reliability and validity of the Longitudinal Interval Follow-Up Evaluation for assessing outcome of anxiety disorders. J Psychiatr Res. 1994;28:531–545
  31. Hollingshead AB. Two factor index of social position. New Haven (CT): Yale University Department of Sociology; 1965;
  32. Cirino PT, Chin CE, Sevcik RA, Wolf M, Lovett M, Morris RD. Measuring socioeconomic status: reliability and preliminary validity for different approaches. Assessment. 2002;9:145–155
  33. Phillips KA, McElroy SL, Keck PE, Pope HG, Hudson JI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry. 1993;150:302–308
  34. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I disorders: non-patient edition (SCID-N/P). New York: New York State Psychiatric Institute; 1996;
  35. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington (DC): American Psychiatric Association; 1994;
  36. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull. 1993;29:321–326
  37. Weissman MM, Prusoff BA, Thompson DW, Harding PS, Myers JK. Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis. 1978;166:317–326
  38. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. Structured Clinical Interview for DSM-IV Axis II personality disorders (SCID-II). Washington (DC): American Psychiatric Press; 1997;
  39. Phillips KA, Hollander E, Rasmussen SA, Aronowitz BR, DeCaria C, Goodman WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacol Bull. 1997;33:17–22
  40. Eisen JL, Phillips KA, Baer L, Beer DA, Atala KD, Rasmussen SA. The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry. 1998;155:102–108
  41. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatr Res. 1986;18:65–87
  42. Miller IW, Bishop S, Norman WH, Maddever H. The modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Res. 1985;14:131–142
  43. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and self-report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004;34:73–82
  44. Rehm LP, O'Hara MW. Item characteristics of the Hamilton Rating Scale for Depression. J Psychiatr Res. 1985;19:31–41
  45. Phillips KA, Pagano ME, Menard W, Stout RL. A 12-month follow-up study of the course of body dysmorphic disorder. Am J Psychiatry. 2006;163:907–912
  46. Rothman K. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43–46
  47. Pinto A, Mancebo MC, Eisen JL, Pagano ME, Rasmussen SA. The Brown longitudinal obsessive compulsive study: clinical features and symptoms of the sample at intake. J Clin Psychiatry. 2006;67:703–711
  48. Reiger DA, Farmer MS, Rae DS, Myers JK, Kramer M, Robins LN, et al. One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiological Catchment Area study. Acta Psychiatr Scand. 1993;88:35–47
  49. Massion AO, Warshaw MG, Keller MB. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry. 1993;150:600–607
  50. Eisen JL, Mancebo MC, Pinto A, Coles ME, Pagano ME, Stout R, et al. Impact of obsessive-compulsive disorder on quality of life. Compr Psychiatry. 2006;47:270–275
  51. Sotsky SM, Glass DR, Shea MT, Pilkonis PA, Collins JF, Elikin I, et al. Patient predictors of response to psychotherapy and pharmacotherapy: findings from the NIMH treatment of depression collaborative research program. Am J Psychiatry. 1991;148:997–1008
  52. Karno M, Golding JM, Sorenson SB, Burman MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45:1094–1099
  53. Bowie CR, Reichenberg A, Patterson TL, Heaton RK, Harvey PD. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry. 2006;163:418–425
  54. Phillips KA, Quinn G, Stout RL. Functional impairment in body dysmorphic disorder: a prospective, follow-up study. J Psychiatr Res. 2008;42:701–770
  55. Phillips KA, Menard W. Suicidality in body dysmorphic disorder. Am J Psychiatry. 2006;163:1280–1282
  56. Wilhelm S, Otto MW, Lohr B, Deckersbach T. Cognitive behavior group therapy for body dysmorphic disorder: a case series. Behav Res Ther. 1999;37:71–75
  57. Veale D, Gournay K, Dryden W, Boocock A, Shah F, Willson R, et al. Body dysmorphic disorder: a cognitive behavioural model and pilot randomised controlled trial. Behav Res Ther. 1996;34:717–729
  58. Rosen JC, Reiter J, Orosan P. Cognitive-behavioral body image therapy for body dysmorphic disorder. J Consult Clin Psychol. 1995;63:263–269

PII: S0010-440X(08)00056-4

doi: 10.1016/j.comppsych.2008.04.003

Comprehensive Psychiatry
Volume 49, Issue 6 , Pages 561-569 , November 2008

Article Tools